NAP protects against cytochrome c release: Inhibition of the initiation of apoptosis

European Journal of Pharmacology

Volumn 618, Issue 1-3, 2009, Pages 9-14

  Zemlyak, Ilona ^a,b   Sapolsky, Robert ^b   Gozes, Illana ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Cortical neuron; Cytochrome c; Microtubule; Neuroprotection; Neuroprotective peptide; Oxygen glucose deprivation

Indexed keywords

ASPARAGINYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; CYTOCHROME C; GLUCOSE; NEUROPROTECTIVE AGENT; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANOXIA; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; FETUS; IMMUNOCYTOCHEMISTRY; MICROSCOPY; MICROTUBULE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CYTOCHROMES C; GLUCOSE; MICROTUBULES; MITOCHONDRIA; NERVE TISSUE PROTEINS; NEURONS; OLIGOPEPTIDES; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING;

EID: 68949176990     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.07.013     Document Type: Article

References (51)

1. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D.E., and Gozes I. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72 (1999) 1283-1293
2. Beni-Adani L., Gozes I., Cohen Y., Assaf Y., Steingart R.A., Brenneman D.E., Eizenberg O., Trembolver V., and Shohami E. A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296 (2001) 57-63
3. Brooke S., Chan R., Howard S., and Sapolsky R. Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9457-9462
4. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell. Dev. Biol. 15 (1999) 269-290
5. Carre M., Andre N., Carles G., Borghi H., Brichese L., Briand C., and Braguer D. Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J. Biol. Chem. 277 (2002) 33664-33669
6. Cattano D., Valleggi S., Ma D., Kastsiuchenka O., Abramo A., Sun P., Cavazzana A.O., Natale G., Maze M., and Giunta F. Xenon induces transcription of ADNP in neonatal rat brain. Neurosci. Lett. 440 (2008) 217-221
7. Chen S., and Charness M.E. Ethanol inhibits neuronal differentiation by disrupting activity-dependent neuroprotective protein signaling. Proc. Natl. Acad. Sci. U. S. A. (2008)
8. Cory S., and Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2 (2002) 647-656
9. Cosgrave A.S., McKay J.S., Bubb V., Morris R., Quinn J.P., and Thippeswamy T. Regulation of activity-dependent neuroprotective protein (ADNP) by the NO-cGMP pathway in the hippocampus during kainic acid-induced seizure. Neurobiol. Dis. 30 (2008) 281-292
10. Divinski I., Holtser-Cochav M., Vulih-Schultzman I., Steingart R.A., and Gozes I. Peptide neuroprotection through specific interaction with brain tubulin. J. Neurochem. 98 (2006) 973-984
11. Divinski I., Mittelman L., and Gozes I. A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. J. Biol. Chem. 279 (2004) 28531-28538
12. Doyle K.P., Simon R.P., and Stenzel-Poore M.P. Mechanisms of ischemic brain damage. Neuropharmacology 55 (2008) 310-318
13. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., and Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell Biol. 143 (1998) 777-794
14. Fujimura M., Morita-Fujimura Y., Murakami K., Kawase M., and Chan P.H. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 18 (1998) 1239-1247
15. Furman S., Steingart R.A., Mandel S., Hauser J.M., Brenneman D.E., and Gozes I. Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron Glia Biol. 1 (2004) 193-199
16. Gozes I. Activity-dependent neuroprotective protein: from gene to drug candidate. Pharmacol. Ther. 114 (2007) 146-154
17. Gozes I., and Divinski I. NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell. Curr. Alzheimer Res. 4 (2007) 507-509
18. Gozes I., and Spivak-Pohis I. Neurotrophic effects of the peptide NAP: a novel neuroprotective drug candidate. Curr. Alzheimer Res. 3 (2006) 197-199
19. Gozes I., Morimoto B.H., Tiong J., Fox A., Sutherland K., Dangoor D., Holser-Cochav M., Vered K., Newton P., Aisen P.S., Matsuoka Y., van Dyck C.H., and Thal L. NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP). CNS Drug Rev. 11 (2005) 353-368
20. Gozes I., Zaltzman R., Hauser J., Brenneman D.E., Shohami E., and Hill J.M. The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury. Curr. Alzheimer Res. 2 (2005) 149-153
21. Gozes I., Stewart A.J., Morimoto B.H., Fox A., Sutherland K., and Schmechel D. Addressing Alzheimer's disease tangles: from NAP to AL-108. Curr. Alzheimer Res. 6 (2009)
22. Graham S.H., and Chen J. Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21 (2001) 99-109
23. Jin H.W., Flatters S.J., Xiao W.H., Mulhern H.L., and Bennett G.J. Prevention of paclitaxel- evoked painful peripheral neuropathy by acetyl-l-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp. Neurol. 210 (2008) 229-237
24. Khaspekov L., Friberg H., Halestrap A., Viktorov I., and Wieloch T. Cyclosporin A and its nonimmunosuppressive analogue N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation- induced damage to rat cultured hippocampal neurons. Eur. J. Neurosci. 11 (1999) 3194-3198
25. Leker R.R., Teichner A., Grigoriadis N., Ovadia H., Brenneman D.E., Fridkin M., Giladi E., Romano J., and Gozes I. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 33 (2002) 1085-1092
26. Longuet M., Serduc R., and Riva C. Implication of bax in apoptosis depends on microtubule network mobility. Int. J. Oncol. 25 (2004) 309-317
27. Mandel S., Spivak-Pohis I., and Gozes I. ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance. J. Mol. Neurosci. 35 (2008) 127-141
28. Matsuoka Y., Jouroukhin Y., Gray A.J., Ma L., Hirata-Fukae C., Li H.F., Feng L., Lecanu L., Walker B.R., Planel E., Arancio O., Gozes I., and Aisen P.S. A neuronal microtubule- interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 325 (2008) 146-153
29. Mironov S.L., Ivannikov M.V., and Johansson M. [Ca2+]i signaling between mitochondria and endoplasmic reticulum in neurons is regulated by microtubules. From mitochondrial permeability transition pore to Ca2+-induced Ca2+ release. J. Biol. Chem. 280 (2005) 715-721
30. Olney J.W., Tenkova T., Dikranian K., Muglia L.J., Jermakowicz W.J., D'Sa C., and Roth K.A. Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol. Dis. 9 (2002) 205-219
31. Olney J.W., Wozniak D.F., Jevtovic-Todorovic V., Farber N.B., Bittigau P., and Ikonomidou C. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol. 12 (2002) 488-498
32. Pascual M., and Guerri C. The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol. J. Neurochem. 103 (2007) 557-568
33. Poggi S.H., Goodwin K., Hill J.M., Brenneman D.E., Tendi E., Schinelli S., Abebe D., and Spong C.Y. The role of activity-dependent neuroprotective protein in a mouse model of fetal alcohol syndrome. Am. J. Obstet. Gynecol. 189 (2003) 790-793
34. Rotstein M., Bassan H., Kariv N., Speiser Z., Harel S., and Gozes I. NAP enhances neurodevelopment of newborn apolipoprotein E-deficient mice subjected to hypoxia. J. Pharmacol. Exp. Ther. 319 (2006) 332-339
35. Santa-Maria I., Smith M.A., Perry G., Hernandez F., Avila J., and Moreno F.J. Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease. Biochim. Biophys. Acta 1740 (2005) 472-480
36. Sari Y., and Gozes I. Brain deficits associated with fetal alcohol exposure may be protected, in part, by peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein. Brain Res. Rev. 52 (2006) 107-118
37. Schmechel D.E., Gerard G., Vatakis N.G., Harper L., Ross J.S., Bari M., Walling D., Stedman M., Winston J.L., Morimoto B., and Keith J.R. A phase 2, double-blind, placebo-controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment. Alzheimer's & Dementia: J. Alzheimer's Assoc 4 4 (2008) T483
38. Seyb K.I., Ansar S., Bean J., and Michaelis M.L. Beta-amyloid and endoplasmic reticulum stress responses in primary neurons: effects of drugs that interact with the cytoskeleton. J. Mol. Neurosci. 28 (2006) 111-123
39. Spong C.Y., Abebe D.T., Gozes I., Brenneman D.E., and Hill J.M. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J. Pharmacol. Exp. Ther. 297 (2001) 774-779
40. Steingart R.A., Solomon B., Brenneman D.E., Fridkin M., and Gozes I. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress. J. Mol. Neurosci. 15 (2000) 137-145
41. Stewart A.J., Fox A., Morimoto B.H., and Gozes I. Looking for novel ways to treat the hallmarks of Alzheimer's disease. Expert Opin. Investig. Drugs 16 (2007) 1183-1196
42. Valleggi S., Cavazzana A.O., Bernardi R., Ma D., Natale G., Maze M., Davide C., and Giunta F. Xenon up-regulates several genes that are not up-regulated by nitrous oxide. J. Neurosurg. Anesthesiol. 20 (2008) 226-232
43. Visochek L., Steingart R.A., Vulih-Shultzman I., Klein R., Priel E., Gozes I., and Cohen-Armon M. PolyADP-ribosylation is involved in neurotrophic activity. J. Neurosci. 25 (2005) 7420-7428
44. Vulih-Shultzman I., Pinhasov A., Mandel S., Grigoriadis N., Touloumi O., Pittel Z., and Gozes I. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J. Pharmacol. Exp. Ther. 323 (2007) 438-449
45. Zaltzman R., Alexandrovich A., Beni S.M., Trembovler V., Shohami E., and Gozes I. Brain injury-dependent expression of activity-dependent neuroprotective protein. J. Mol. Neurosci. 24 (2004) 181-187
46. Zaltzman R., Alexandrovich A., Trembovler V., Shohami E., and Gozes I. The influence of the peptide NAP on Mac-1-deficient mice following closed head injury. Peptides 26 (2005) 1520-1527
47. Zamostiano R., Pinhasov A., Gelber E., Steingart R.A., Seroussi E., Giladi E., Bassan M., Wollman Y., Eyre H.J., Mulley J.C., Brenneman D.E., and Gozes I. Cloning and characterization of the human activity-dependent neuroprotective protein. J. Biol. Chem. 276 (2001) 708-714
48. Zemlyak I., Furman S., Brenneman D.E., and Gozes I. A novel peptide prevents death in enriched neuronal cultures. Regul. Pept. 96 (2000) 39-43
49. Zemlyak I., Manley N., Sapolsky R., and Gozes L. NAP protects hippocampal neurons against multiple toxins. Peptides 28 (2007) 2004-2008
50. Zhao H., Yenari M.A., Cheng D., Sapolsky R.M., and Steinberg G.K. Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J. Cereb. Blood Flow Metab. 25 (2005) 1119-1129
51. Zou H., Li Y., Liu X., and Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274 (1999) 11549-11556